Literature DB >> 32816618

Ferroptosis: a new unexpected chance to treat metastatic melanoma?

Mara Gagliardi1,2, Valentina Saverio1,2, Romina Monzani1,2, Eleonora Ferrari1,2, Mauro Piacentini3,4, Marco Corazzari1,2,5.   

Abstract

Human skin melanoma is one of the most aggressive and difficult to treat human malignancies, with an increasing incidence over the years. While the resection of the early diagnosed primary tumor remains the best clinical approach, advanced/metastatic melanoma still remains with a poor prognosis. Indeed, although enormous progress in the therapeutic treatment of human tumors has been made in recent years, patients affected by metastatic melanoma are still poorly affected by these clinical advances. Therefore, new valuable therapeutic approaches are urgently needed, to design and define effective treatments to consistently increase the overall survival rate of patients affected by this malignancy. In this review we summarize the main signaling pathways studied to kill human skin melanoma, and introduce the ferroptotic cell death as a new pathway to be explored to eradicate this tumor.

Entities:  

Keywords:  AKR; Ferroptosis; NRF2; lipid-ROS; melanoma

Year:  2020        PMID: 32816618      PMCID: PMC7553499          DOI: 10.1080/15384101.2020.1806426

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  93 in total

Review 1.  Genetic alterations of PTEN in human melanoma.

Authors:  Almass-Houd Aguissa-Touré; Gang Li
Journal:  Cell Mol Life Sci       Date:  2011-11-11       Impact factor: 9.261

Review 2.  Long-chain acyl-CoA synthetase in fatty acid metabolism involved in liver and other diseases: an update.

Authors:  Sheng Yan; Xue-Feng Yang; Hao-Lei Liu; Nian Fu; Yan Ouyang; Kai Qing
Journal:  World J Gastroenterol       Date:  2015-03-28       Impact factor: 5.742

Review 3.  The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress.

Authors:  Truyen Nguyen; Paul Nioi; Cecil B Pickett
Journal:  J Biol Chem       Date:  2009-01-30       Impact factor: 5.157

4.  Ferroptosis as a p53-mediated activity during tumour suppression.

Authors:  Le Jiang; Ning Kon; Tongyuan Li; Shang-Jui Wang; Tao Su; Hanina Hibshoosh; Richard Baer; Wei Gu
Journal:  Nature       Date:  2015-03-18       Impact factor: 49.962

5.  Cystine-glutamate transporter SLC7A11 in cancer chemosensitivity and chemoresistance.

Authors:  Ying Huang; Zunyan Dai; Catalin Barbacioru; Wolfgang Sadée
Journal:  Cancer Res       Date:  2005-08-15       Impact factor: 12.701

6.  A cell cycle regulator potentially involved in genesis of many tumor types.

Authors:  A Kamb; N A Gruis; J Weaver-Feldhaus; Q Liu; K Harshman; S V Tavtigian; E Stockert; R S Day; B E Johnson; M H Skolnick
Journal:  Science       Date:  1994-04-15       Impact factor: 47.728

Review 7.  Oncology meets immunology: the cancer-immunity cycle.

Authors:  Daniel S Chen; Ira Mellman
Journal:  Immunity       Date:  2013-07-25       Impact factor: 31.745

Review 8.  BRAF signaling and targeted therapies in melanoma.

Authors:  Nathalie Dhomen; Richard Marais
Journal:  Hematol Oncol Clin North Am       Date:  2009-06       Impact factor: 3.722

9.  Innate Immune Pathways Associated with Lung Radioprotection by Soy Isoflavones.

Authors:  Lisa M Abernathy; Matthew D Fountain; Michael C Joiner; Gilda G Hillman
Journal:  Front Oncol       Date:  2017-01-23       Impact factor: 6.244

Review 10.  Immature, Semi-Mature, and Fully Mature Dendritic Cells: Toward a DC-Cancer Cells Interface That Augments Anticancer Immunity.

Authors:  Aleksandra M Dudek; Shaun Martin; Abhishek D Garg; Patrizia Agostinis
Journal:  Front Immunol       Date:  2013-12-11       Impact factor: 7.561

View more
  10 in total

1.  Development and Validation of a Novel Ferroptosis-Related LncRNA Signature for Predicting Prognosis and the Immune Landscape Features in Uveal Melanoma.

Authors:  Xiaochen Ma; Sejie Yu; Bin Zhao; Wei Bai; Yubo Cui; Jinglan Ni; Qinghua Lyu; Jun Zhao
Journal:  Front Immunol       Date:  2022-06-14       Impact factor: 8.786

2.  The International Society of RNA Nanotechnology and Nanomedicine (ISRNN): The Present and Future of the Burgeoning Field.

Authors:  Morgan Chandler; Brittany Johnson; Emil Khisamutdinov; Marina A Dobrovolskaia; Joanna Sztuba-Solinska; Aliasger K Salem; Koen Breyne; Roger Chammas; Nils G Walter; Lydia M Contreras; Peixuan Guo; Kirill A Afonin
Journal:  ACS Nano       Date:  2021-10-22       Impact factor: 18.027

3.  Construction and Validation of a 6-Ferroptosis Related Gene Signature for Prognosis and Immune Landscape Prediction in Melanoma.

Authors:  Zhanghui Yue; Jianfang Sun; Liqing Shi
Journal:  Front Genet       Date:  2022-05-25       Impact factor: 4.772

Review 4.  NRF2 and the Ambiguous Consequences of Its Activation during Initiation and the Subsequent Stages of Tumourigenesis.

Authors:  Holly Robertson; Albena T Dinkova-Kostova; John D Hayes
Journal:  Cancers (Basel)       Date:  2020-12-02       Impact factor: 6.639

5.  A Novel Ferroptosis-Related lncRNA Prognostic Model and Immune Infiltration Features in Skin Cutaneous Melanoma.

Authors:  Shuya Sun; Guanran Zhang; Litao Zhang
Journal:  Front Cell Dev Biol       Date:  2022-02-03

6.  Identification and validation of a prognostic model for melanoma patients with 9 ferroptosis-related gene signature.

Authors:  Yuxuan Chen; Linlin Guo; Zijie Zhou; Ran An; Jiecong Wang
Journal:  BMC Genomics       Date:  2022-03-30       Impact factor: 3.969

7.  Melanoma Molecular Subtypes and Development of Prognostic and Immunotherapy-Related Genetic Characteristics by Ferroptosis Gene Analysis.

Authors:  Libin Xu; Yu Zhang; Ting Liu; Luqiang Wang; Zhenguo Zhao; Xinxin Zhang; Xiaoyang Li; Wence Wu; Shengji Yu
Journal:  Comput Math Methods Med       Date:  2022-04-26       Impact factor: 2.809

Review 8.  Ferroptosis: A New Road towards Cancer Management.

Authors:  Iqra Bano; Pavel Horky; Syed Qamar Abbas; Muhammad Majid; Akram Hafiz Muhammad Bilal; Fawad Ali; Tapan Behl; Syed Shams Ul Hassan; Simona Bungau
Journal:  Molecules       Date:  2022-03-25       Impact factor: 4.411

9.  Starvation mediates pancreatic cancer cell sensitivity to ferroptosis via ERK1/2, JNK and changes in the cell mesenchymal state.

Authors:  Egle Zalyte; Jonas Cicenas
Journal:  Int J Mol Med       Date:  2022-05-06       Impact factor: 5.314

10.  Identification and validation of ferroptosis-related lncRNA signature as a prognostic model for skin cutaneous melanoma.

Authors:  Sen Guo; Jianru Chen; Xiuli Yi; Zifan Lu; Weinan Guo
Journal:  Front Immunol       Date:  2022-09-29       Impact factor: 8.786

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.